Sign up
Log in
What's Going On With Oscar Health Stock On Wednesday?
Share
Listen to the news

Oscar Health Inc. (NYSE:OSCR) is trading lower on Wednesday, with no apparent news to explain the move. Year-to-date, the stock has gained roughly 15%.

Last week, the healthcare technology company announced a partnership with grocery chain Hy-Vee to launch a new employer health insurance plan, "Hy-Vee Health with Oscar."

The plan will debut in Des Moines, Iowa, covering 400,000 local employees through the individual marketplace starting Nov. 1, with coverage effective Jan. 1, 2026.

Employer-backed coverage in the individual market (ICHRA) can save businesses 20% to 30% and employees $500 to $1,000 per year. Hy-Vee and Oscar plan to expand the benefit to additional markets over time.

Also Read: Oscar Health Well-Positioned To Manage Market Reset, Eyes Profitability In 2026

Earlier in August, Oscar Health reported second-quarter revenue of approximately $2.86 billion, compared to $2.2 billion in the same period the previous year, missing the consensus estimate of $2.91 billion.

The sales increase was primarily driven by higher membership.

The healthcare technology company reported a loss of 89 cents per share, missing the consensus estimate of 86 cents.

The medical loss ratio was 91.1% for the second quarter of 2025, compared to 79.0% for the same quarter in 2024, primarily driven by an increase in average market morbidity that led to a higher net risk adjustment transfer accrual.

Guidance: Oscar Health reaffirms its fiscal 2025 sales guidance of $12 billion to $12.2 billion, compared to the Wall Street estimate of $11.32 billion.

The company expects a 2025 medical loss ratio of 86% to 87%.

The broader health insurance sector received a boost after high-profile investors Michael Burry and Warren Buffett took positions in industry giant UnitedHealth Group Inc. (NYSE:UNH), lifting sentiment for peers like Oscar.

Price Action: OSCR stock is down 7.73% at $15.34 at the last check on Wednesday.

Read Next:

Image: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.